Fundraising FoxJefferies — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US
R.A. Session II(Executive Officer, Director)inSean P. Nolan(Chief Executive Officer and Board Chairman)in
BoardPaul B. Manning(Director)in
Co-investorsBios PartnersGV (Google Ventures)BairdGoldman SachsPBM Capital
Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients.
BiotechDeep TechMedical Devices
Co-investorsCapDecisif ManagementHEALTHCARE ROYALTY PARTNERSKaristaSeventure Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.